Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03805672 · ClinicalTrials.gov registry record · Phase 4
Below Knee DVT Study
A Phase 4 study, sponsored by Oregon Health and Science University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 4
- Enrollment target
NCT03805672: Clinical Trial Phase 4 study, sponsored by Oregon Health and Science University.
NCT03805672 is a Phase 4 study that was terminated before completion, run by Oregon Health and Science University. The registered enrollment target is 4 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03805672, a Phase 4 study, was terminated before completion, sponsored by Oregon Health and Science University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 4 participants
- Enrollment target
Study Summary
Hospitalized patients are at risk of developing blood clots in the legs (Deep Vein Thrombosis or DVT), which can lead to death if those clots break off and migrate to the lungs. We know that if there is a blood clot in the large leg veins near the hips and in the thighs, treating these patients with high-doses of blood thinners reduces the risk of these deaths. It is unclear if treating blood clots in the calf with high doses of blood thinners is better than using low doses. In this study, after being diagnosed with a blood clot in the calf, patients will be treated with either low dose or high dose enoxaparin (Lovenox), a blood thinner. We will then see if low dose blood thinner has similar results as high dose blood thinner.
Primary Outcome
Evaluation of DVT resolution
Interventions
- DRUG Low Dose Enoxaparin
- DRUG High Dose Enoxaparin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-07 |
| Phase | Phase 4 |
Why NCT03805672 stopped before completion
NCT03805672 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Low Dose Enoxaparin is the first listed.
NCT03805672 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03805672 about?
NCT03805672 is a clinical study titled "Below Knee DVT Study". Hospitalized patients are at risk of developing blood clots in the legs (Deep Vein Thrombosis or DVT), which can lead to death if those clots break off and migrate to the lungs. We know that if there is a blood clot in the large leg veins near the hips and in the thighs, treating these patients with...
What is the current status of trial NCT03805672?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 4 participants. The study started on 2014-09. Estimated completion is 2015-07.
What interventions are being tested in trial NCT03805672?
The interventions under investigation include: Low Dose Enoxaparin (DRUG), High Dose Enoxaparin (DRUG).
Who is sponsoring clinical trial NCT03805672?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03805672's enrollment target sits among peer trials
4 1994th of 2000 higher than 6 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia